Metraipolis › archive › dc_fc5200fcb8d6

Considerations for establishing occupational exposure limits for small molecule kinase inhibitors in drug development — Europe PMC PMID:41960283

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41960283
DOI
10.3389/ftox.2026.1743558
License (as archived)
solo-consultazione
Archived
2026-11-03T20:35:49.539Z
SHA-256 of the archived text
3d3e1c84b7ff8064a0c1a7ba6a6750d49f9539734cae9cd4a61929994709ee28
Stable URL of this page
https://metraipolis.com/documento/dc_fc5200fcb8d6

How to cite

Considerations for establishing occupational exposure limits for small molecule kinase inhibitors in drug development — Europe PMC PMID:41960283 — Europe PMC (en), https://europepmc.org/article/MED/41960283 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fc5200fcb8d6 (Metraipolis archive dc_fc5200fcb8d6, sha256 3d3e1c84b7ff8064a0c1a7ba6a6750d49f9539734cae9cd4a61929994709ee28)
BibTeX
@misc{dcfc5200fcb8d6,
  title = {Considerations for establishing occupational exposure limits for small molecule kinase inhibitors in drug development — Europe PMC PMID:41960283},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41960283},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fc5200fcb8d6; sha256 3d3e1c84b7ff8064a0c1a7ba6a6750d49f9539734cae9cd4a61929994709ee28},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41960283. Agents can read the archived copy with the MCP tool read_document.